Characterization of the Genetic Features of NPM1-Mutated Myeloid Sarcoma and NPM1-Mutated AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group
Leukemia and Lymphoma 2023 Mar 24;[EPub Ahead of Print], M Ramia de Cap, LP Wu, C Hirt, GA Pihan, SS Patel, W Tam, CE Bueso-Ramos, R Kanagal-Shamanna, PW Raess, A Siddon, D Narayanan, EA Morgan, GS Pinkus, EF Mason, ED Hsi, HJ Rogers, L Toth, K Foucar, SN Hurwitz, A Bagg, A Rets, TI George, A Orazi, DA Arber, RP Hasserjian, OK WeinbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.